What's Next in Health Data with Veritas Data Research

With the value and sensitivity of health data hitting all-time highs, leaders are now faced with a defining question: how do you ensure the real-world data guiding your strategy is complete, reliable and differentiated?

In part one of Datavant’s What’s Next in Health Data series, Jason Labonte, CEO at Veritas Data Research, joins Arnaub Chatterjee, President & GM of Life Sciences at Datavant, for a fireside discussion on how mortality data is redefining health data utility.

Together, Jason and Arnaub will discuss how leading organizations are:

• Leveraging mortality data in new healthcare research use cases, including as a differentiator in trials.
• Moving beyond the “fact of death” to richer, cause-specific insights
• Using next-generation tools and infrastructure to leverage sensitive data securely and at scale.

Designed for an audience across health data strategy, research, and commercialization, this 30-minute fireside chat will explore the inputs and endpoints shaping the next era of mortality data.